Many assumed that Black investment in Pennsylvania’s budding medical marijuana industry would be found in the Southeast region around Philadelphia, and any other Black investment would be at best, minimal.
But in the Greene County town of Carmichaels, there is not only Black investment, but Black ownership of what will be one of only two state-sanctioned medical marijuana farms in the Southwest region.
And AGRiMED Industries’ plans don’t stop there. The company has also applied for a dispensary license, which, if granted, would give the company control of the product from cultivation to sale.
“AGRiMED is so pleased to be able to bring real economic opportunities back to Greene County, which is one county among many that have been hit hard by the economic downturn over the last few decades.”The firm’s entire African American leadership team, which includes managing partner Sterling Crockett, Board Chair Ron Goldman and Medical Director Dr. Eric Mitchell, thanked the Pennsylvania Department of Health in a statement released immediately after the winning firms were announced:
“We are honored to have been selected by the Commonwealth of Pennsylvania to be one of the first medical cannabis cultivators given the opportunity to begin the process of relief to the pain and suffering of the citizens of Pennsylvania. The selection of AGRiMED today provides us with the opportunity to achieve some of our own company’s core values. One of these goals is empowering underserved and underrepresented communities. AGRiMED is so pleased to be able to bring real economic opportunities back to Greene County, which is one county among many that have been hit hard by the economic downturn over the last few decades.”
The statement continued, “Another of AGRiMED’s goals is improving the quality of life for as many people as possible. This drives AGRiMED’s desire to harness the natural power of the cannabis plant to create nature-based medicines capable of relieving a growing list of ailments. Improving the quality of life is also why AGRiMED will work with and educate local community caregivers to provide our cannabis-infused medicines to patients in need of alternatives to pain management in the face of the opioid epidemic.”